Core promoter variants (A-20C, T-18C and G-6A) of the angiotensinogen (AGT) gene are not significantly associated with hypertension in patients of Tamilnadu, India

International Journal of Human Genetics

Volumn 9, Issue 1, 2009, Pages 13-19

  Karthikeyan, M ^a,d   Rose, Rajiv ^a   Shridevi, V ^a   Anandan, B ^a   Shanmugasundaram, S ^b   Mohan, D ^c   Ramesh, A ^a   Jayaraman, G ^a  

^a UNIVERSITY OF MADRAS   (India)

^b KS Hospital   (India)

^c Govt Hospital   (India)

^d ALAGAPPA UNIVERSITY   (India)

Author keywords

AGT gene polymorphism; Blood pressure; Disease association; Promoter variants

Indexed keywords

ANGIOTENSINOGEN;

AFRICA; ARTICLE; ASIAN; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DNA SEQUENCE; ETHNIC GROUP; EVOLUTION; FLUID BALANCE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SELECTION; GENOTYPE; HUMAN; HYPERTENSION; INDIA; MAJOR CLINICAL STUDY; PROMOTER REGION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RURAL POPULATION; SINGLE STRAND CONFORMATION POLYMORPHISM; SODIUM BALANCE; URBAN POPULATION;

EID: 75749093641     PISSN: 09723757     EISSN: None     Source Type: Journal    
DOI: 10.1080/09723757.2009.11886056     Document Type: Article

References (38)

1. 235 → Thr variant of angio-tensinogen gene in severe, family hypertension. Biophys Biophys Res Commun, 197: 833-839.
2. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, et al 1999. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens, 21(5-6): 1009-1060.
3. Chaves FJ, Pascul JM, Rovira E, Armengod ME, Rodon J 2001. Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension. Am J Hypertens, 14: 364-370.
4. Chaves FJ, Giner V, Corella D, Pascual J, Marin P, et al 2002. Body weight changes and the A-6G polymorphism of the angiotensinogen gene. In J Obes Relat Metab Disord, 26: 1173-1178.
5. Chiang FT, Hsu KL, Tseng CD, Hsiao WH, Lo HM, Chern TH and Tseng YZ 1997. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens, 15: 607-611.
6. Cui Y, Narayanan CS, Zhou J, Kumar A 1998. Exon-I is involved in positive as well as negative regulation of human angiotensinogen gene expression. Gene, 224 (1-2): 97-107.
7. Cvetkovic B, Keen H, Zhang X, Davis D, Yang B, et al 2002. Physiological significance of two common haplotypes of human angiotensinogen using gene targeting in the mouse. Physiol genomics, 11: 253-262.
8. Hegele RA, Harris SB, Hanley AJ, Sun F, Connelly PW, et al 1997. Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension, 29(5): 1073-1077.
9. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, et al 1994. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest, 93: 1285-1287.
10. Hunt SC, Cook NR, Oberman A, Cutler JA, Hennekens CH, et al 1998. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension, 32 (3): 393-401.
11. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, et al 1997. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest, 99(7): 1786-1797.
12. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, et al 1992. Molecular basis of human hypertension: role of angiotensinogen. Cell, 71(1): 169-180.
13. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, et al 1997. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet, 60(6): 1448-1460.
14. Joint National Committee (JNC) on prevention, detection, evaluation and treatment of high blood pressure: The Sixth report of National high blood pressure education programme, National Lung and blood institute, National Institute of Health 1997. Arch Inter Med, 157: 2413-2446.
15. Joint National Committee (JNC) on prevention, detection, evaluation and treatment of high blood pressure: The Seventh report: National Institute of Health publication, 2003; No. 03-5233; 1-34.
16. Kamitani A, Rakugi H, Higaki J, Yi Z, Mikami H, et al 1994. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens, 8(7): 521-524.
17. Kong X, Zhang S, Yang Y, Zheng K, Tong Y, et al 2002. The relationship between haplotypes of angiotensinogen gene and essential hypertension. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 19(6): 488-490. Abstract.
18. Li CC 1961. Human genetics- principles and methods. McGraw - Hill Inc pp. 89-98.
19. Li R, Nicklas B, Pahor M, Newman A, Sutton-Tyrrell K, Harris T, et al 2007. Polymorphisms of angiotensinogen and angiotensin-converting enzyme associated with lower extremity arterial disease in the Health, Aging and Body Composition study. J Hum Hypertens, 21(8):673-82.
20. Markovic D, Tang X, Guruju M, Levenstien MA, Hoh J, et al 2005. Association of angiotensinogen gene polymorphisms with essential hypertension in African-Americans and Caucasians. Hum Hered, 60 (2): 89-96.
21. Marciante KD, Bis JC, Rieder MJ, Reiner AP, Lumley T, et al 2007. Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients. Am J Epidemiol, 166(1): 19-27.
22. Miller SA, Dykes DD and Polesy HF 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nuc Acid Res, 102: 103-106.
23. Nakajima T, Jorde LB, Ishigami T, Umemura S, Emi M, et al 2002. Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet, 70(1): 108-23.
24. Nakajima T, Wooding S, Sakagami T, Emi M, Tokunaga K, et al 2004. Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet, 74(5): 898-916.
25. Peng H, Du M, Ji J, Isaacson PG and Pan L 1995. High-resolution SSCP analysis using poltacrlamide agarose composite gel and a background free silver staining method. Biotechnique, 19: 411-414.
26. Petrovic D, Bidovec M, Peterlin B 2002. Gene polymorphisms of the renin-angiotensin- aldo-sterone system and essential arterial hypertension in childhood. Folia Biol (Krakow), 50(1-2): 53-56.
27. Province MA, Boerwinkle E, Chakravarti A, Cooper R, Fornage M, et al 2000. Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program. National Heart, Lung and Blood Institute. J Hypertens, 18(7): 867-76.
28. Rodriguez-Perez JC, Rodriguez -Esparragon FJ, Hernandez-Perera O, Fiuza-Perez MD, Anabitarte Prieto A, Losada-Cabrera A 2000. Effects of the angiotensinogen gene M235T and A-6G variants in blood pressure and other vascular risk factors in a Spanish population. J Hum Hypertens, 14 (12): 789-793.
29. Rotimi CN 2003. Genetic ancestry tracing and the African identity: a double-edged sword? Developing World Bioeth, 3 (2): 151-158.
30. Redon J, Luque-Otero M, Martell N, Chaves FJ 2005. Renin-angiotensin system gene polymorphism: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients. Pharmacogenomics J, 5: 14-20.
31. Sato N, Katsuya T, Rakugi H, Takami S, Nakata Y, et al 1997. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension, 30 (3 Pt 1): 321-325.
32. Sato N, Katsuya T, Nakagawa T, Ishikawa K, Fu Y, et al 2000. Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci, 68 (3): 259-272.
33. Shlyakhto EV, Shwartz EI, Nefedova YB, Zukova AV, Vinnic TA, Conrady AO 2001. Lack of association of the renin-angiotensin system genes polymorphisms and left ventricular hypertrophy in hypertension. Blood Press, 10 (3): 135-141.
34. Tiago Ad, Samani NJ, Candy GP, Brooksbank R, Libhaber EN, Sareli P, et al 2002. Angiotensinogen gene promoter region variant modifies body size-Ambulatory blood pressure relations in hypertension. Circulation, 106 (12): 1483-1487.
35. Wallace AJ 1997. Combined single strand conformation polymorphism and heteroduplex analysis. Chapter 8. In: GR Talyor (Ed.): Laboratory Methods for the Detection of Mutations and Polymorphisms in DNA, pp 79-94.
36. Wu SJ, Chiang FT, Jiang JR, Hsu KL, Chenn TH et al 2003. The G-217A variant of the angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese population. J Hypertens, 21(11): 2061-2067.
37. Yanai K, Nibu Y, Murakami K, Fukamizu A 1996. A cisacting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J Biol Chem, 271 (27): 15981-15986.
38. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A 1999. Role of C/A polymorphism at-20 on the expression of human angiotensinogen gene. Hypertension, 33(1): 108-115.